Stammdaten
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Unternehmen & Branche
| Name | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. |
|---|---|
| Ticker | CELZ |
| CIK | 0001187953 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 5,7 Mio. USD |
| Beta | 1,99 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 6,000 | -5,995,008 | -2.52 | 7,809,525 | 7,514,645 |
| 2025-09-30 | 10-Q | 0 | -1,235,934 | -0.48 | 5,853,003 | 5,591,650 |
| 2025-06-30 | 10-Q | 0 | -1,233,303 | -0.48 | 7,105,228 | 6,827,584 |
| 2025-03-31 | 10-Q | 3,000 | -1,638,097 | 0.83 | 8,347,274 | 8,060,887 |
| 2024-12-31 | 10-K | 11,000 | -5,493,481 | -3.71 | 6,669,143 | 6,341,499 |
| 2024-09-30 | 10-Q | 0 | -1,040,135 | -0.75 | 6,887,919 | 6,557,011 |
| 2024-06-30 | 10-Q | 8,000 | -1,557,728 | -1.11 | 7,989,706 | 7,613,434 |
| 2024-03-31 | 10-Q | 0 | -1,041,544 | 0.73 | 9,619,577 | 9,228,618 |
| 2023-12-31 | 10-K | 9,000 | -5,286,574 | -3.76 | 10,715,190 | 10,343,796 |
| 2023-09-30 | 10-Q | 6,000 | -1,453,952 | 12,513,539 | 12,092,380 | |
| 2023-06-30 | 10-Q | 0 | -1,102,125 | 14,127,477 | 13,728,950 | |
| 2023-03-31 | 10-Q | 0 | -1,051,923 | 15,229,449 | 14,821,913 | |
| 2022-12-31 | 10-K | 88,600 | -10,144,044 | -0.93 | 19,186,326 | 15,864,674 |
| 2022-09-30 | 10-Q | 55,000 | -982,339 | -0.07 | 22,468,161 | 22,071,204 |
| 2022-06-30 | 10-Q | 0 | -1,791,144 | -0.20 | 23,434,164 | 23,044,369 |
| 2022-03-31 | 10-Q | 15,000 | -1,154,869 | -0.18 | 9,734,026 | 9,354,231 |
| 2021-12-31 | 10-K | 87,754 | 19,211,768 | 5.61 | 11,268,181 | 10,217,740 |
| 2021-09-30 | 10-Q | 10,000 | -1,843,596 | -0.75 | 3,131,912 | -363,345 |
| 2021-06-30 | 10-Q | 10,000 | -2,905,182 | -1.25 | 732,309 | -714,453 |
| 2021-03-31 | 10-Q | 0 | 27,836,019 | 11.18 | 871,876 | -2,442,573 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.